药物对比
Dapagliflozin vs Saxagliptin
Dapagliflozin与Saxagliptin：SGLT2抑制剂与DPP-4抑制剂治疗2型糖尿病。比较疗效、心脏/肾脏获益、副作用、减重效果及Qtern复方制剂。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes deciding between an SGLT2 inhibitor and a DPP-4 inhibitor, especially those with cardiovascular or renal disease.
结论
Dapagliflozin typically provides broader cardiorenal benefits than saxagliptin, yet the optimal drug is determined by individual patient factors.
全部药物对比